The UK medicines regulator has approved the use of Pfizer and AstraZeneca as Covid booster vaccines, paving the way for a rollout ahead of the winter. But the Joint Committee on Vaccination and ...

In July, AstraZeneca declared a worldwide cessation of its COVID-19 vaccine, Vaxzevria, due to an “excess of updated vaccines.” Earlier, Pfizer raised its 2024 guidance to $8.5 billion from $8 ...

Two vaccines were studied: those made by Pfizer and AstraZeneca. So, is mix and match an option? The trial’s results are preliminary, having yet to be reviewed by other scientists, but the answer ...

In August, the Food and Drug Administration authorized updated vaccines against COVID-19. Here's what to know about the three ...

Covid vaccines from companies like Pfizer, Moderna and AstraZeneca were linked to rare occurrences of heart, brain and blood ...

Findings highlight the Pfizer-BioNTech vaccine’s role in preventing MIS-C, a rare post-COVID inflammatory syndrome in ...

NHS frontline staff, care home residents and workers, and the over 80s are first in line to receive the two vaccines being rolled out in the UK - Pfizer and Oxford University/AstraZeneca jab.

Unverified data about events after vaccinations is not evidence that the vaccine caused the event, as suggested in social ...

Platelets are cells that help your blood clot, and it was so unusual to see blood clots combined with low platelet levels, that experts coined a new medical term: vaccine-induced thrombosis with ...

Q3 results confirms that the U.S. vaccine market for respiratory syncytial virus (RSV), led by Pfizer (PFE) and GSK (GSK), is ...

Abrysvo is the first vaccine for the respiratory syncytial virus that is indicated for adults younger than 50, the drugmaker ...

We expect Pfizer's falling COVID-19 vaccine and treatment sales will create ... The failed attempts to acquire AstraZeneca and Allergan are partly concerning, but several factors outside Pfizer ...